339 related articles for article (PubMed ID: 31031778)
1. Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.
Elbahesh H; Gerlach T; Saletti G; Rimmelzwaan GF
Front Immunol; 2019; 10():809. PubMed ID: 31031778
[TBL] [Abstract][Full Text] [Related]
2. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
3. Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.
Ramos I; Smith G; Ruf-Zamojski F; Martínez-Romero C; Fribourg M; Carbajal EA; Hartmann BM; Nair VD; Marjanovic N; Monteagudo PL; DeJesus VA; Mutetwa T; Zamojski M; Tan GS; Jayaprakash C; Zaslavsky E; Albrecht RA; Sealfon SC; García-Sastre A; Fernandez-Sesma A
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375585
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
[TBL] [Abstract][Full Text] [Related]
5. The Nonstructural NS1 Protein of Influenza Viruses Modulates
Dubois J; Traversier A; Julien T; Padey B; Lina B; Bourdon JC; Marcel V; Boivin G; Rosa-Calatrava M; Terrier O
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651364
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
7. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics.
Ulyanova V; Shah Mahmud R; Laikov A; Dudkina E; Markelova M; Mostafa A; Pleschka S; Ilinskaya O
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167434
[TBL] [Abstract][Full Text] [Related]
8. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.
Fu Y; Gaelings L; Söderholm S; Belanov S; Nandania J; Nyman TA; Matikainen S; Anders S; Velagapudi V; Kainov DE
Antiviral Res; 2016 Sep; 133():23-31. PubMed ID: 27451344
[TBL] [Abstract][Full Text] [Related]
9. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
[TBL] [Abstract][Full Text] [Related]
10. Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine.
Söderholm S; Anastasina M; Islam MM; Tynell J; Poranen MM; Bamford DH; Stenman J; Julkunen I; Šaulienė I; De Brabander JK; Matikainen S; Nyman TA; Saelens X; Kainov D
Antiviral Res; 2016 Feb; 126():69-80. PubMed ID: 26738783
[TBL] [Abstract][Full Text] [Related]
11. Emerging cellular targets for influenza antiviral agents.
Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
[TBL] [Abstract][Full Text] [Related]
12. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.
Holthausen DJ; Lee SH; Kumar VT; Bouvier NM; Krammer F; Ellebedy AH; Wrammert J; Lowen AC; George S; Pillai MR; Jacob J
Immunity; 2017 Apr; 46(4):587-595. PubMed ID: 28423338
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
[TBL] [Abstract][Full Text] [Related]
14. Influenza Virus Infections and Cellular Kinases.
Meineke R; Rimmelzwaan GF; Elbahesh H
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791550
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
[TBL] [Abstract][Full Text] [Related]
16. Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
Shim JM; Kim J; Tenson T; Min JY; Kainov DE
Viruses; 2017 Aug; 9(8):. PubMed ID: 28805681
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Nonstructural Proteins of Influenza A Viruses.
Klemm C; Boergeling Y; Ludwig S; Ehrhardt C
Trends Microbiol; 2018 Jul; 26(7):624-636. PubMed ID: 29373257
[TBL] [Abstract][Full Text] [Related]
18. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory therapy for severe influenza.
Darwish I; Mubareka S; Liles WC
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):807-22. PubMed ID: 21810053
[TBL] [Abstract][Full Text] [Related]
20. The Class IV human deacetylase, HDAC11, exhibits anti-influenza A virus properties via its involvement in host innate antiviral response.
Nutsford AN; Galvin HD; Ahmed F; Husain M
Cell Microbiol; 2019 Apr; 21(4):e12989. PubMed ID: 30511515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
